03/10/2015 - 3:38pm

ANI Pharmaceuticals acquired the approved abbreviated new drug application for flecainide acetate tablets USP in 50-mg, 100-mg and 150-mg dosage strengths.

03/10/2015 - 2:46pm

The Food and Drug Administration recently published bio-equivalence guidance documents. 

03/10/2015 - 1:19pm

Actavis expanded its portfolio of topicals with the launch of a generic corticosteroid.

03/10/2015 - 10:55am

Impax Labs completed its acquisition of Tower Holdings (which includes operating subsidiaries CorePharma and Amedra Pharmaceuticals), and Lineage Therapeutics. Impax also announced that it would reshape both the operating and reporting structure of its two divisions.

03/09/2015 - 2:40pm

Apple on Monday better enabled medical research with the launch of open source software framework ResearchKit. 

03/02/2015 - 4:56pm

The FDA is expected to issue new guidance on biosimilars labeling and generic opioids before the end of year, according to a report by the Regulatory Affairs Professional Society.

03/02/2015 - 1:08pm

The implementation of an e-prescribing mandate in New York hits a snag as state legislators agree to a delay.

03/02/2015 - 9:42am

Mylan on Friday announced the successful completion of the acquisition of Abbott Laboratories' non-U.S. developed markets specialty and branded generics business.

02/27/2015 - 5:25pm

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker.